Phenome-Wide Risk Evaluation of GLP-1 Receptor Agonist Use in Type 2 Diabetes with Real-World Data Across Multiple Healthcare Systems. - Vashisht R; Dhruva SS; Patel A; Dahm L; Morris P; Gonzalez D; Follett R; Sirota M; Singh K; Han C; Koliwad S; Butte AJ (MedRxiv : the preprint server for health sciences, 2025)